SCHEMBL22561759

SCHEMBL22561759

C=C(N/C(C)=C\C)c1ccc2ccccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 2/20 0.45
ALDH1A1 P00352 1/20 0.45
EGFR P00533 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45
JAK1 P23458 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
F2 P00734 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29851622 0.81 CES2 (0.53) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL6904379 0.81 CES2 (0.53) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL14313666 0.80 NPC1 (0.54) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL1554584 0.74 CES2 (0.56) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL29521283 0.74 CES2 (0.56) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL30999689 0.74 CES2 (0.56) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL7570852 0.72 CES2 (0.54) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL28539564 0.72 CES2 (0.54) KMT2AKDM4EHPGDSMN1; SMN2MEN1
SCHEMBL24098662 0.72 SMN1; SMN2 (0.42) SMN1; SMN2MAPTCES2CES1NPC1
Ammonia Solution, Strong SCHEMBL27845641 0.71 CES2 (0.52) KMT2AKDM4EHPGDSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3409668-B1 NOVEL IMIDAZOLE DERIVATIVE HAVING JNK INHIBITORY ACTIVITY AND USE THEREOF SAMJIN PHARM CO LTD (KR) 2020-10-21 EP disclosed